New Cancer Drug Shrinks Tumors in 61% of Patients
A targeted therapy for advanced gastrointestinal cancer shrank tumors by 30% or more in 61% of patients who tried it as their first treatment. The breakthrough could offer hope to those facing drug resistance in a cancer that affects thousands worldwide.